Answers are grounded in this paper and cite their sources.
Major depressive disorder has complex pathophysiology. It is critical to understand treatment-resistant depression (TRD) specifically, as there are many patients for whom no sufficient treatment exists. In this study we assess volumetric differences in hippocampal subfields between TRD patients and healthy controls (HC) using automatic segmentation of hippocampal subfields and ultra-high field MRI. 13 TRD patients and 13 HC underwent imaging using 7-Tesla MRI. ASHS software produced automated hippocampal segmentation for volumetric analysis. Compared to HC, TRD patients showed reduced right-hemisphere CA2/3 subfield volume. Determining biomarkers for TRD pathophysiology may elucidate the underlying mechanisms of treatment-resistant depression.
No takes yet. Share an insight, caveat, or question.
Alper et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: